Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen, Bas Groot Koerkamp, Stefan Buettner, Andrea Wang‐Gillam(Washington University in St. Louis), Matthew H. G. Katz(The University of Texas MD Anderson Cancer Center), Jaswinder S. Samra(The University of Sydney), Matthew J. Weiss(Northwell Health), Marc G. Besselink(Amsterdam Neuroscience), Brian A. Boone(West Virginia University), Niek A. Peters(Utrecht University), Christoph Tinchon(LKH Hochsteiermark), Jessica M. Frakes(Moffitt Cancer Center), Ian Chau(Royal Marsden NHS Foundation Trust), Georgios Antonios Margonis(Memorial Sloan Kettering Cancer Center), Pietro Addeo(Hôpitaux Universitaires de Strasbourg), Philippe Bachellier(Hôpitaux Universitaires de Strasbourg), Mary Dillhoff(The Ohio State University Wexner Medical Center), Geertjan van Tienhoven, Martin D. McCarter(University of Colorado Cancer Center), Sing Yu Moorcraft(National Health Service), Alessandro Paniccia(University of Colorado Anschutz Medical Campus), Sunhee S. Kim, Jill Lacy(Smilow Cancer Hospital), Hans Rabl, Bassel F. El‐Rayes(University of Alabama at Birmingham), Eran van Veldhuisen(Amsterdam Neuroscience), Peter J. Hosein(Markey Cancer Center), Song Cheol Kim(Ulsan College), Berend R. Beumer(Erasmus University Rotterdam), Andrew H. Ko(University of California, San Francisco), Maria Antonietta Bali(Royal Marsden NHS Foundation Trust), Khurum Khan(Institute of Cancer Research), Eric A. Mellon(Henry Ford Health System), Nigel B. Jamieson(University of Glasgow), Hiroki Yamaue(Wakayama Medical University), Nathan Bahary(University of Pittsburgh Medical Center), Stephen Clarke(The University of Sydney), Tanios Bekaii‐Saab(WinnMed), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Derek Grose, Ammar A. Javed(NYU Langone Health), Ken‐ichi Okada(Wakayama Medical University), Colin J. McKay(Glasgow Royal Infirmary), Johanna W. Wilmink, Kyu-pyo Kim, Mustafa Suker(Erasmus MC Cancer Institute), Parag J. Parikh(Henry Ford Hospital), Casper H.J. van Eijck(Erasmus MC)
Cited by 299
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k